1 | Examination Report | 07 Sep 2006 |
10 | Letters related to TOP | 16 Jul 2018 |
11 | Order | 25 Feb 2020 |
2 | TM-1 | 07 Sep 2006 |
3 | Other Documents | 07 Sep 2006 |
4 | Additional Representation Sheet | 24 Jan 2007 |
4 | Note Sheet | 24 Jan 2007 |
5 | Hearing Notice | 24 Jan 2007 |
5 | Note Sheet | 24 Jan 2007 |
6 | Additional Representation Sheet | 24 Jan 2007 |
6 | Hearing Notice | 24 Jan 2007 |
7 | Affidavit | 01 Mar 2017 |
8 | Journal Copy | 13 Mar 2017 |
9 | TM-O(NOTICE OF OPPOSITION) | 20 Jun 2017 |
1 | Hearing Notice (Adjourned) | 4288419 | 1990016 | 07 Dec 2016 |
2 | Hearing Notice (Adjourned) | 4475287 | 2015192 | 30 Jan 2017 |
3 | Tribunal ABA Notice for : 1524422 | 4589907 | 2041185 | 01 Mar 2017 |
4 | Opposition Notice | 5217525 | 12 Oct 2017 | |
5 | Opposition Counter Statement | 6451685 | 2863579 | 01 Jun 2018 |
As per IP India data the trademark was applied on 24 January 2007.
MACLEODS PHARMACEUTICALS applied for Moximac.
Listed class of trademark Moximac is 5.
Moximac is on the Abandoned stage of the trademark process.
Serial Number provided to trademark application is 1524422
The trademark is categorized as WORD.